Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[Inebilizumab]1件: Inebilizumab (inebilizumab-cdon)1件: Inebilizumab (Inebilizumab, Inebilizumab-cdon) 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 300 💬
2INEBILIZUMAB1件: Inebilizumab (inebilizumab-cdon)1件: Inebilizumab (Inebilizumab, Inebilizumab-cdon) 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬8件: 11, 13, 46, 49, 51, 53, 95, 300 💬
3Inebilizumab + Rapid Steroid Tapering group1件: Inebilizumab (inebilizumab-cdon)1件: Inebilizumab (Inebilizumab, Inebilizumab-cdon) 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 13 💬
4Inebilizumab + Standard Steroid Tapering group1件: Inebilizumab (inebilizumab-cdon)1件: Inebilizumab (Inebilizumab, Inebilizumab-cdon) 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 13 💬
5Rapid-tapering glucocorticoids + Inebilizumab1件: Inebilizumab (inebilizumab-cdon)1件: Inebilizumab (Inebilizumab, Inebilizumab-cdon) 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 13 💬
6Slow-tapering glucocorticoids + Inebilizumab1件: Inebilizumab (inebilizumab-cdon)1件: Inebilizumab (Inebilizumab, Inebilizumab-cdon) 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 13 💬